Complete loss of PAX5 function is required for leukemogenesis, as all heterozygous carriers of germline variants in PAX5 who develop B-ALL show somatic inactivation of the second allele [16,74]. This evidence concerns the gene PAX5 and precursor B-cell acute lymphoblastic leukemia.